Provided is a immunoglobulin that binds IgE with high affinity. The antibody is capable of inhibiting cells that express membrane-anchored IgE. Also, the antibody is useful for treating IgE-mediated disorders, including allergies and asthma.
Figure 1 Effects of anti-IgE mAbs on spontaneous and ragweed-specific histamine release.
Histamine release was performed as previously published, Inhibition of ragweed-induced histamine release was measured by coincubating anti-IgE mAbs with lOOng/ml ragweedspecific
IgE for 2 h at 37°C followed by a 30-min challenge with 100 ng/ml ragweed antigen. Data represents I of 3 experiments.
Shields, R. L., Werther, W. R., Zioncheck, K., O’Connell, L., Klassen, T., Fendly, B., ... & Jardieu, P. M. (1995). Anti-lgE monoclonal antibodies that inhibit allergen-specific histamine release. International archives of allergy and immunology, 107(1-3), 412-413.
Figure 2 Binding of recombinant FcεRI α subunit on CUO3DI0 cells and anti-IgE mAbs (Mae-11, -13 and -17) to recombinant C,3 domain mutants.
Mutants were prepared [4], transiently expressed and quantified by ELISA. Binding of CHO cells to 1 ug/ml IgE mutants was measured by immunofluorescence and analyzed by flow cytometry, and binding to anti-IgE mAbs was measured by ELISA. Values are the average of duplicate determinations from 1 of 3 experiments.
Shields, R. L., Werther, W. R., Zioncheck, K., O’Connell, L., Klassen, T., Fendly, B., ... & Jardieu, P. M. (1995). Anti-lgE monoclonal antibodies that inhibit allergen-specific histamine release. International archives of allergy and immunology, 107(1-3), 412-413.
Figure 3 Hllmanized MaEll mAb blocks AgE-mediated contraction and histamine release from passively sensitized human lung parenchyma.
Human lung strips were incubated with a 1 : 10 dilution of human ragweed serum for 20 hours in the presence of an equimolar concentration of MaE11 or a IO-fold excess concentration of control anti-IgE mAb, MaEl. The lo-fold excess concentration of MaEl inhibited histamine release (A) and tissue contraction (B) in response to AgE challenge by about 50%. In contrast, equimolar concentrations of MaEll completely blocked both histamine release (A) and tissue contraction (B) in response to AgE challenge. Results are expressed as the mean ± SEM of five separate experiments.
Saban, R., Haak-Frendscho, M., Zine, M., Ridgway, J., Gorman, C., Presta, L. G., ... & Jardieu, P. (1994). Human FcERI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitization of human and rhesus monkey lung. Journal of allergy and clinical immunology, 94(5), 836-843.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-034ZJ | Anti-Human IgE Recombinant Antibody (CMAB007) | ELISA | Humanized antibody |
TAB-049ZJ | Anti-Human IgE Recombinant Antibody (IGE009) | ELISA, Inhib, FC | Humanized antibody |
TAB-034ZJ-S(P) | Anti-Human IgE Recombinant Antibody scFv Fragment (CMAB007) | ELISA | Humanized antibody |
TAB-049ZJ-S(P) | Anti-Human IgE Recombinant Antibody scFv Fragment (IGE009) | ELISA, Inhib, FC | Humanized antibody |
TAB-050ZJ-S(P) | Anti-Human IgE Recombinant Antibody scFv Fragment (IGE026) | ELISA, Inhib, FC | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-095ZJ | Anti-Human IgE Therapeutic Single Domain Antibody (39D11) | ELISA, Inhib, FC | Single domain antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-009LC | Recombinant Anti-Human IgE Antibody (Fab glycosylation/Fc glycosylation) | ELISA, IP | Human antibody |
Gly-010LC | Recombinant Anti-Human IgE Antibody (Fab glycosylation/Fc glycosylation) | ELISA, IP | Human antibody |
Gly-011LC | Recombinant Anti-Human IgE Antibody (Fab glycosylation/Fc glycosylation) | ELISA, IP | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-009LC-1 | Recombinant Anti-Human IgE Antibody (Fab glycosylation/Fc glycosylation) | ELISA, IP | Human antibody |
Gly-010LC-1 | Recombinant Anti-Human IgE Antibody (Fab glycosylation/Fc glycosylation) | ELISA, IP | Human antibody |
Gly-011LC-1 | Recombinant Anti-Human IgE Antibody (Fab glycosylation/Fc glycosylation) | ELISA, IP | Human antibody |
Gly-156LC | Recombinant Anti-Human IgE Antibody (Fc glycosylation/Non fucosylated) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-156LC-1 | Recombinant Anti-Human IgE Antibody (Fc glycosylation/Non fucosylated) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0209CQ-S(P) | Human Anti-IgE Recombinant Antibody (clone huTES-C21); scFv Fragment | ELISA, Block | Humanized scFv |
HPAB-0519-WJ-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-0519-WJ-S(P)) | ELISA | Human scFv |
HPAB-0520-WJ-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-0520-WJ-S(P)) | ELISA | Human scFv |
HPAB-0521-WJ-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-0521-WJ-S(P)) | ELISA | Human scFv |
HPAB-1572WJ-S(P) | Mouse Anti-IgE Recombinant Antibody; scFv Fragment (clone MAE13) | ELISA, WB, FC | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0283-YJ | Mouse Anti-IgE Recombinant Antibody (HPAB-0283-YJ) | ELISA, Enzymatic activity | Mouse IgG |
HPAB-0521-WJ | Human Anti-IgE Recombinant Antibody (HPAB-0521-WJ) | ELISA | Human IgG1 |
HPAB-1195-FY | Human Anti-IgE Recombinant Antibody (HPAB-1195-FY) | ELISA | Human IgG |
HPAB-1196-FY | Human Anti-IgE Recombinant Antibody (HPAB-1196-FY) | ELISA | Human IgG |
HPAB-1197-FY | Human Anti-IgE Recombinant Antibody (HPAB-1197-FY) | ELISA | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1195-FY-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-1195-FY-S(P)) | ELISA | Human scFv |
HPAB-1196-FY-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-1196-FY-S(P)) | ELISA | Human scFv |
HPAB-1197-FY-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-1197-FY-S(P)) | ELISA | Human scFv |
HPAB-1198-FY-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-1198-FY-S(P)) | ELISA | Human scFv |
HPAB-1199-FY-S(P) | Human Anti-IgE Recombinant Antibody; scFv Fragment (HPAB-1199-FY-S(P)) | ELISA | Human scFv |
There are currently no Customer reviews or questions for HPAB-AP678-YC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.